GO
Loading...

Gilead Sciences Inc

More

  • Midday Glance: Biotechnology companies Friday, 28 Nov 2014 | 2:11 PM ET

    Amgen Inc. rose$. 59 or. 4 percent, to $165.31. Biogen Idec rose $2.77 or. 9 percent, to $307.69. Celgene Corp. rose $1.08 or 1.0 percent, to $113.69.

  • Early Glance: Biotechnology companies Friday, 28 Nov 2014 | 10:28 AM ET

    Amgen Inc. rose $1.98 or 1.2 percent, to $166.70. Biogen Idec rose $5.08 or 1.7 percent, to $310.00. Celgene Corp. rose $1.55 or 1.4 percent, to $114.16.

  • Final Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose $2.48 or 1.5 percent, to $164.72. Biogen Idec fell$. 48 or. 2 percent, to $304.92. Celgene Corp. rose $1.54 or 1.4 percent, to $112.61.

  • Midday Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 2:02 PM ET

    Amgen Inc. rose $1.39 or. 9 percent, to $163.63. Biogen Idec fell $1.87 or. 6 percent, to $303.53. Celgene Corp. rose $1.31 or 1.2 percent, to $112.38.

  • Bristol-Myers said it had initially sought permission from the U.S. Food and Drug Administration to market the drug, a so-called NS5A inhibitor, in combination with asunaprevir, one of the New York- based company's experimental medicines. But Bristol-Myers abandoned its U.S. marketing application for asunaprevir in October because of potential...

  • Early Glance: Biotechnology companies Wednesday, 26 Nov 2014 | 10:24 AM ET

    Amgen Inc. rose$. 92 or. 6 percent, to $163.16. Biogen Idec fell $1.90 or. 6 percent, to $303.50. Celgene Corp. rose$. 73 or. 7 percent, to $111.80.

  • Final Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 6:57 PM ET

    Amgen Inc. fell $1.94 or 1.2 percent, to $162.24. Biogen Idec fell $1.34 or. 4 percent, to $305.40. Celgene Corp. rose$. 09 or. 1 percent, to $111.07.

  • Most active Nasdaq-traded stocks Tuesday, 25 Nov 2014 | 1:18 PM ET

    Apple Inc. fell. 8 percent to $117.66 with 38,369,600 shares traded. Cisco Systems Inc. rose. 7 percent to $27.22 with 14,180,100 shares traded. Facebook Inc. rose 1.6 percent to $75.20 with 18,544,700 shares traded.

  • Midday Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 1:17 PM ET

    Amgen Inc. fell $1.86 or 1.1 percent, to $162.32. Biogen Idec fell $2.53 or. 8 percent, to $304.21. Celgene Corp. fell$. 15 or. 1 percent, to $110.83.

  • Early Glance: Biotechnology companies Tuesday, 25 Nov 2014 | 10:22 AM ET

    Amgen Inc. fell $2.11 or 1.3 percent, to $162.07. Biogen Idec fell$. 12 or percent, to $306.62. Celgene Corp. fell$. 35 or. 3 percent, to $110.63.

  • Final Glance: Biotechnology companies Monday, 24 Nov 2014 | 6:08 PM ET

    Amgen Inc. rose $1.37 or. 8 percent, to $164.18. Biogen Idec rose $3.19 or 1.1 percent, to $306.74. Celgene Corp. rose $2.78 or 2.6 percent, to $110.98.

  • Most active Nasdaq-traded stocks Monday, 24 Nov 2014 | 1:26 PM ET

    American Realty Capital Properties Inc. rose. 5 percent to $9.04 with 17,481,400 shares traded. Apple Inc. rose 1.9 percent to $118.63 with 45,726,300 shares traded. Ariad Pharmaceuticals Inc. rose 9.7 percent to $7.15 with 16,632,100 shares traded.

  • Early Glance: Biotechnology companies Monday, 24 Nov 2014 | 10:26 AM ET

    Amgen Inc. rose $2.73 or 1.7 percent, to $165.54. Biogen Idec rose $3.62 or 1.2 percent, to $307.17. Celgene Corp. rose $2.12 or 2.0 percent, to $110.32.

  • Final Glance: Biotechnology companies Friday, 21 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 13 or. 1 percent, to $162.81. Biogen Idec rose $4.45 or 1.5 percent, to $303.55. Celgene Corp. rose$. 85 or. 8 percent, to $108.20.

  • Early Glance: Biotechnology companies Friday, 21 Nov 2014 | 10:17 AM ET

    Amgen Inc. fell$. 16 or. 1 percent, to $162.52. Biogen Idec rose $3.56 or 1.2 percent, to $302.66. Celgene Corp. rose $1.30 or 1.2 percent, to $108.65.

  • Final Glance: Biotechnology companies Thursday, 20 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 04 or percent, to $162.68. Biogen Idec fell $4.51 or 1.5 percent, to $299.10. Celgene Corp. rose$. 37 or. 3 percent, to $107.35.

  • Midday Glance: Biotechnology companies Thursday, 20 Nov 2014 | 2:49 PM ET

    Amgen Inc. rose $1.79 or 1.1 percent, to $164.43. Biogen Idec fell $1.84 or. 6 percent, to $301.78. Celgene Corp. rose$. 60 or. 6 percent, to $107.58.

  • Early Glance: Biotechnology companies Thursday, 20 Nov 2014 | 10:29 AM ET

    Amgen Inc. rose$. 44 or. 3 percent, to $163.08. Biogen Idec fell$. 30 or. 1 percent, to $303.31. Celgene Corp. fell$. 16 or. 2 percent, to $106.82.

  • Nov 20- Global pharmaceutical spending will break the trillion dollar mark in 2014, driven by high prices in the United States for novel treatments such as Gilead Sciences Inc's Sovaldi for hepatitis C and new cancer drugs, according to a study released on Thursday. Total spending on drugs will hit $1.06 trillion, an increase of 7 percent over 2013 levels,...

  • Final Glance: Biotechnology companies Wednesday, 19 Nov 2014 | 6:02 PM ET

    Amgen Inc. rose$. 40 or. 2 percent, to $162.64. Biogen Idec fell $1.95 or. 6 percent, to $303.61. Celgene Corp. rose$. 20 or. 2 percent, to $106.98.